Home  »  Stocks to Invest   »  NAOV Stock More Than Triples Over A Week...

NAOV Stock More Than Triples Over A Week

NanoVibronics Inc (NASDAQ: NAOV) stock has prevailed in the market nowadays. The NAOV stock price has taken an upswing by 221.46℅ the previous week. It climbed up to $0.82 from July 22 to $2.41at the last check. Moreover, displays a high market price change of 26.18% at the recent close.NAOV is higher by $2.41 from the previous closing price of $1.94 on the volume of 220221008 shares. Over the past half-year, NAOV stocks price is elevated by 107.76%.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Why NAOV has taken a Surge

NAOV is a medical company that manufactures UroShield and PainShield Surface Acousticc Wave (SAW) Portable Ultrasonic Therapeutic Devices. It develops noninvasive biological response-activating tools that target biofilm deterrence, pain therapy, and damage recovery.

Investors have been responding positively to the stock. The company affirmed that it has fulfilled the first order of its next-generation pain management machine called PainShield plus. Also, it is expecting to reach high revenue in the third quarter of 2021.

The specialty of  PainShield Plus is that it covers two times the surface area of pain therapy. Resultantly, it is sold at a higher gross margin when compared to the original Pain Shield MD. This device is also beneficial in preventing opioid therapies and equips patients to acquire treatment independently in the convenience and protection of their own houses.

NAOV’sdealings with Authority

The company on 29 July has disclosed that it has allotted a license by Therapeutic Goods Administration (TGA), The Australian Regulatory body for Therapeutics, for its UroShield, to be used by patients in Australia. Additionally, the company proclaimed that it has signed a treaty with DukeHill Healthcare Pty Ltd (DukeHill HC) to distribute the Company’s UroShield and PainShield technologies all around Australia. These deals are tangible milestones towards the commercialization of the products. Hence, holding up the stock’s price to gain significantly.

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam